{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:59:10Z","timestamp":1790110750912,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nefro.2016.11.018","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T05:47:28Z","timestamp":1506145648000},"page":"515-525","source":"Crossref","is-referenced-by-count":22,"title":["La infecci\u00f3n por citomegalovirus postrasplante renal y p\u00e9rdida del injerto a largo plazo"],"prefix":"10.1016","volume":"37","author":[{"given":"Mar\u00eda Ovidia","family":"L\u00f3pez-Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Escuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Selgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2016.11.018_bib0185","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"NEJM"},{"issue":"Supl 6","key":"10.1016\/j.nefro.2016.11.018_bib0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0213-005X(11)70050-7","article-title":"Efectos indirectos de la infecci\u00f3n por citomegalovirus","volume":"29","author":"Cast\u00f3n Osorio","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.nefro.2016.11.018_bib0195","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1034\/j.1600-6143.2003.00069.x","article-title":"The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis","volume":"3","author":"Schnitzler","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2016.11.018_bib0215","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.tp.0000230460.42558.b0","article-title":"The natural course of cytomegalovirus infection and disease in renal transplant recipients","volume":"82","author":"Hartmann","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0220","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-004-1499-z","article-title":"Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation","volume":"47","author":"Hjelmesaeth","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.nefro.2016.11.018_bib0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2016.11.018_bib0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-0012.2006.00639.x","article-title":"Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk","volume":"21","author":"Sagedal","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ctr.12288","article-title":"The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival","volume":"28","author":"Smedbraten","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2016.11.018_bib0245","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1111\/j.1432-2277.2000.tb02059.x","article-title":"Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival","volume":"13","author":"Schneeberger","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.nefro.2016.11.018_bib0250","first-page":"293","article-title":"Tratamiento profil\u00e1ctico por citomegalovirus en pacientes trasplantados renales mediante valganciclovir oral","volume":"28","author":"Guirado","year":"2008","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2016.11.018_bib0255","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/TP.0000000000000522","article-title":"Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients","volume":"99","author":"Opeltz","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0260","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nefro.2016.11.018_bib0265","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/01.TP.0000137105.92464.F3","article-title":"Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation","volume":"78","author":"Nett","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0270","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/ajt.12388","article-title":"Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients","volume":"13","author":"Manuel","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0275","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.nefro.2016.11.018_bib0280","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/cit945","article-title":"A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant","volume":"58","author":"Florescu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nefro.2016.11.018_bib0285","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1399-3062.2011.00652.x","article-title":"Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials","volume":"13","author":"Zhang.","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.nefro.2016.11.018_bib0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of calganciclovir vs. Oral ganciclovirfor prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0295","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0300","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.V1281758","article-title":"Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction","volume":"12","author":"Giral","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2016.11.018_bib0305","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.ASN.0000051599.09435.1E","article-title":"Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: The importance of HLA-DR matching","volume":"14","author":"Schnitzler","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2016.11.018_bib0310","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0315","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00007890-200103270-00013","article-title":"Cytomegalovirus infection and graft rejection in renal transplantation","volume":"71","author":"Dickenmann","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0320","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1399-0012.1996.tb00735.x","article-title":"A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival","volume":"10","author":"Eriksson","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0325","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcv.2012.12.010","article-title":"Limited impact of cytomegalovirus in the long-term outcome of renal and liver transplant","volume":"56","author":"San Juan","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.nefro.2016.11.018_bib0330","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: Two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0335","doi-asserted-by":"crossref","unstructured":"Owers DS, Webster AC, Strippoli GFM, Kable K, Hodson EM. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (review). Cochrane database Syst Rev 2013; Issue 2.","DOI":"10.1002\/14651858.CD005133.pub3"},{"key":"10.1016\/j.nefro.2016.11.018_bib0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2016.11.018_bib0345","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jit064","article-title":"Cytomegalovirus exposure and cardiovascular disease in kidney transplant patients","volume":"207","author":"Courivaud","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nefro.2016.11.018_bib0350","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ajt.12049","article-title":"Pre-transplant interferon-\u03b3 secretion by CMV-specific CD8 T cells informs the risk of CMV replication after transplantation","volume":"13","author":"Cantis\u00e1n","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0355","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/ajt.12256","article-title":"Pre-transplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2016.11.018_bib0360","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.TP.0000438025.96334.eb","article-title":"Pre-transplant CD8-T cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant","volume":"97","author":"L\u00f3pez-Oliva","year":"2014","journal-title":"Transplantation"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516302132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516302132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T21:40:25Z","timestamp":1750887625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699516302132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0211699516302132"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2016.11.018","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}